Cover Image
市場調查報告書

小型皮下輸液設備

Small Form Factor Subcutaneous Infusion Systems

出版商 Greystone Research Associates 商品編碼 366043
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
小型皮下輸液設備 Small Form Factor Subcutaneous Infusion Systems
出版日期: 2016年08月09日 內容資訊: 英文
簡介

本報告提供小型的各種皮下輸液設備的市場調查,現在市售或開發中的小型皮下輸液設備與其供應商,主要的設計因素、材料、技術,需求推進因素分析,對應皮下輸液設備的藥物、疾病領域,以及主要企業的簡介等彙整。

摘要整理

注射劑/投入的藥劑市場動態

  • 藥物開發趨勢
  • 藥物輸送設備的演進
  • 患者的自我施打趨勢
  • 實行技術

皮下輸液設備:設計因素

  • 數量和粘度
  • 一次包裝
  • 注射法
  • 患者接口系統

皮下注射設備:對象市場

  • 高粘度藥
  • 大容量藥
  • 注射時間

皮下輸液設備:設備分析

  • OEM設備
    • Crono
    • Enable Injector
    • Flex-Therapy
    • Libertas
    • OmniPod
    • Precision-Therapy
    • SensePatch
    • SmartDose
  • 自家公司用設備
  • 產品專用設備

皮下輸液設備:近幾年的產品

  • Amgen
  • AstraZeneca
  • Baxter
  • Britannia
  • Capricor
  • CSL Behring
  • GlaxoSmithKline
  • Grifols
  • Ferring
  • Janssen
  • NeuroDerm
  • Octapharma
  • Roche
  • Rhythm Metabolic
  • scPharmceuticals
  • SteadyMed
  • 武田藥品工業
  • United Therapeutics
  • UCB
  • US Worldmeds
  • 皮下注射劑:各疾病領域
    • 自體免疫疾病
    • 心臟血管
    • 血液
    • 免疫
    • 感染疾病
    • 代謝性疾病
    • 神經
    • 癌症
    • 生殖健康
    • 其他潛在的市場
  • 市場因素
    • 自我施打、服藥遵守
    • 法規指引、產品的認證
    • 藥物產品的差異化
  • 企業簡介
目錄
Product Code: SFF469R

As currently formulated, a significant number of therapeutic drugs require dosage volumes or possess viscosities well in excess of the upper range for traditional subcutaneous delivery. These drugs are currently delivered via infusion. The demographics of patient populations and the current trend in therapeutic drug development are converging to create an increasingly steep demand curve for infusion. The costs and logistics of this convergence are a major driver of the energy behind small form factor subcutaneous infusion systems. As the adoption of and acceptance of self-administered therapies grows, patients are spending less time with physicians and are playing a greater role in the delivery and management of their treatments. This dramatic shift in healthcare delivery is creating a need for devices that mask an underlying layer of complexity via design initiatives that are patient-friendly.

What You Will Learn

  • What small form factor (SFF) subcutaneous infusion systems are currently marketed or in development, who are the suppliers, and what are the device specifics?
  • What are the therapeutic markets being targeted by SFF subcutaneous infusion systems?
  • What are the essential design factors, material selection issues, technologies and market development issues for SFF subcutaneous infusion systems?
  • What are the major factors that will drive SFF subcutaneous infusion systems demand?
  • How are SFF subcutaneous infusion systems currently aligned with various drug classes and therapeutic markets?
  • What is the addressable market for SFF subcutaneous infusion systems?
  • What is the expected impact of SFF subcutaneous infusion systems on drug delivery markets?
  • Who are the significant players in this segment? What are their strategies? Who are their alliance partners?

Table of Contents

Executive Summary

Injectable/Infusible Market Segment Dynamics

  • Drug Development Trends
  • Drug Delivery Device Evolution
  • The Trend toward Patient Self-Administration
  • Enabling Technology

Subcutaneous Infusion Systems - Design Factors

  • Volumes and Viscosities
  • Primary Packaging
  • Injection Methodology
  • Patient Interface

Subcutaneous Infusion Device - Addressable Market

  • High Viscosity Drugs
  • High Volume Drugs
  • Duration Dependent Administration Drugs

Subcutaneous Infusion Systems - Device Analysis

  • OEM Devices
  • Crono
  • Enable Injector
  • Flex-Therapy
  • Libertas
  • OmniPod
  • Precision-Therapy
  • SensePatch
  • SmartDose
  • Captive Devices
  • Product-specific Devices

Subcutaneous Infusions System - Near-term Products

  • Amgen
  • AstraZeneca
  • Baxter
  • Britannia
  • Capricor
  • CSL Behring
  • GlaxoSmithKline
  • Grifols
  • Ferring
  • Janssen
  • NeuroDerm
  • Octapharma
  • Roche
  • Rhythm Metabolic
  • scPharmceuticals
  • SteadyMed
  • Takeda
  • United Therapeutics
  • UCB
  • US Worldmeds
  • Subcutaneous Infusion Therapeutics - Segment Analysis
  • Autoimmune Diseases
  • Cardiovascular
  • Hematology
  • Immunology
  • Infectious Diseases
  • Metabolic Diseases
  • Neurology
  • Oncology
  • Reproductive Health
  • Other Potential Markets
  • Market Factors
  • Self-Administration and Patient Compliance
  • Regulatory Guidance and Product Approvals
  • Drug Product Differentiation
  • Company Profiles
Back to Top